U.S Physical Therapy Basic EPS 2010-2024 | USPH

U.S Physical Therapy basic eps from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
U.S Physical Therapy Annual Basic EPS
2023 $1.28
2022 $2.25
2021 $2.41
2020 $2.48
2019 $2.45
2018 $1.31
2017 $1.76
2016 $1.64
2015 $1.66
2014 $1.57
2013 $1.05
2012 $1.52
2011 $1.78
2010 $1.34
2009 $1.01
U.S Physical Therapy Quarterly Basic EPS
2024-06-30 $0.47
2024-03-31 $0.46
2023-12-31 $-0.45
2023-09-30 $0.51
2023-06-30 $0.64
2023-03-31 $0.58
2022-12-31 $-0.01
2022-09-30 $0.72
2022-06-30 $0.87
2022-03-31 $0.67
2021-12-31 $0.72
2021-09-30 $0.66
2021-06-30 $0.82
2021-03-31 $0.21
2020-12-31 $0.68
2020-09-30 $0.61
2020-06-30 $0.99
2020-03-31 $0.20
2019-12-31 $0.55
2019-09-30 $0.66
2019-06-30 $0.85
2019-03-31 $0.39
2018-12-31 $0.43
2018-09-30 $0.13
2018-06-30 $0.48
2018-03-31 $0.27
2017-12-31 $0.58
2017-09-30 $0.41
2017-06-30 $0.39
2017-03-31 $0.38
2016-12-31 $0.42
2016-09-30 $0.38
2016-06-30 $0.48
2016-03-31 $0.36
2015-12-31 $0.37
2015-09-30 $0.47
2015-06-30 $0.48
2015-03-31 $0.34
2014-12-31 $0.35
2014-09-30 $0.43
2014-06-30 $0.52
2014-03-31 $0.27
2013-12-31 $0.31
2013-09-30 $0.02
2013-06-30 $0.41
2013-03-31 $0.31
2012-12-31 $0.34
2012-09-30 $0.39
2012-06-30 $0.41
2012-03-31 $0.38
2011-12-31 $0.69
2011-09-30 $0.35
2011-06-30 $0.42
2011-03-31 $0.32
2010-12-31 $0.36
2010-09-30 $0.33
2010-06-30 $0.38
2010-03-31 $0.27
2009-12-31 $0.20
2009-09-30 $0.27
2009-06-30 $0.31
2009-03-31 $0.23
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.428B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.039B 12.12
Quest Diagnostics (DGX) United States $17.877B 18.12
DaVita (DVA) United States $12.667B 16.38
Encompass Health (EHC) United States $10.405B 24.53
Chemed (CHE) United States $8.459B 26.00
Elanco Animal Health (ELAN) United States $7.054B 16.79
RadNet (RDNT) United States $6.388B 141.61
Option Care Health (OPCH) United States $3.890B 18.43
Amedisys (AMED) United States $3.035B 21.60
LifeStance Health (LFST) United States $2.828B 0.00
Addus HomeCare (ADUS) United States $2.320B 27.22
Astrana Health (ASTH) United States $2.297B 36.01
Pennant (PNTG) United States $1.162B 46.99
Aveanna Healthcare Holdings (AVAH) United States $1.149B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.042B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00